Brenner Erin K. Insider Trades

Insider Trading History

Track insider trading activity for Brenner Erin K.. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Pear Therapeutics- Warrants (01/12/2026)
Pear Therapeutics- Warrants (01/12/2026) PEARW
Chief Product Dev. Officer
Holding Value $5.62k 952,380 shares
Last Trade
Feb 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$100k 952,380 shares
$0.11
$0.01
Pear Therapeutics
Pear Therapeutics PEAR
Chief Product Dev. Officer
Holding Value $27.8k 952,380 shares
Last Trade
Feb 15, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1M 952,380 shares
$1.05
$0.03
Pear Therapeutics
Pear Therapeutics PEAR
Chief Product Dev. Officer
Holding Value $1.26k 43,310 shares
Last Trade
Jan 20, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$9.82k 8,690 shares
$1.13
$0.03
Pear Therapeutics- Warrants (01/12/2026)
Pear Therapeutics- Warrants (01/12/2026) PEARW
Chief Product Dev. Officer
Holding Value $256 43,310 shares
Last Trade
Jan 20, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$1.04k 8,690 shares
$0.12
$0.01
Pear Therapeutics- Warrants (01/12/2026)
Pear Therapeutics- Warrants (01/12/2026) PEARW
Chief Product Dev. Officer
Holding Value $307 52,000 shares
Last Trade
Jan 14, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.64k 22,000 shares
$0.12
$0.01
Pear Therapeutics- Warrants (01/12/2026)
Pear Therapeutics- Warrants (01/12/2026) PEARW
Chief Product Dev. Officer
Holding Value $264 44,667 shares
Last Trade
Jan 14, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.64k 22,000 shares
$0.12
$0.01
Pear Therapeutics
Pear Therapeutics PEAR
Chief Product Dev. Officer
Holding Value $1.3k 44,667 shares
Last Trade
Jan 14, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$27.1k 22,000 shares
$1.23
$0.03
Pear Therapeutics
Pear Therapeutics PEAR
Chief Product Dev. Officer
Holding Value $1.52k 52,000 shares
Last Trade
Jan 14, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$27.1k 22,000 shares
$1.23
$0.03
Pear Therapeutics- Warrants (01/12/2026)
Pear Therapeutics- Warrants (01/12/2026) PEARW
Chief Product Dev. Officer
Holding Value $532 90,234 shares
Last Trade
Dec 09, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.63k 15,000 shares
$0.18
$0.01
Pear Therapeutics
Pear Therapeutics PEAR
Chief Product Dev. Officer
Holding Value $2.63k 90,234 shares
Last Trade
Dec 09, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$29.1k 15,000 shares
$1.94
$0.03
Pear Therapeutics
Pear Therapeutics PEAR
Chief Product Dev. Officer
Holding Value $876 30,000 shares
Last Trade
Dec 09, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$29.1k 15,000 shares
$1.94
$0.03
Pear Therapeutics- Warrants (01/12/2026)
Pear Therapeutics- Warrants (01/12/2026) PEARW
Chief Product Dev. Officer
Holding Value $177 30,000 shares
Last Trade
Dec 09, 2022 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.63k 15,000 shares
$0.18
$0.01
Pear Therapeutics- Warrants (01/12/2026)
Pear Therapeutics- Warrants (01/12/2026) PEARW
Chief Product Dev. Officer
Holding Value $621 105,234 shares
Last Trade
May 25, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$6.7k 15,000 shares
$0.45
$0.01
Pear Therapeutics
Pear Therapeutics PEAR
Chief Product Dev. Officer
Holding Value $3.07k 105,234 shares
Last Trade
May 25, 2022 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$61.7k 15,000 shares
$4.11
$0.03
Pear Therapeutics- Warrants (01/12/2026)
Pear Therapeutics- Warrants (01/12/2026) PEARW
Chief Product Dev. Officer
Holding Value $393 66,667 shares
Last Trade
Feb 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.6k 52,520 shares
$0.62
$0.01
Pear Therapeutics
Pear Therapeutics PEAR
Chief Product Dev. Officer
Holding Value $1.95k 66,667 shares
Last Trade
Feb 16, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$484k 119,187 shares
$4.06
$0.03
Pear Therapeutics- Warrants (01/12/2026)
Pear Therapeutics- Warrants (01/12/2026) PEARW
Chief Product Dev. Officer
Holding Value $709 120,234 shares
Last Trade
Dec 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$436k 399,987 shares
$1.09
$0.01
Pear Therapeutics
Pear Therapeutics PEAR
Chief Product Dev. Officer
Holding Value $3.51k 120,234 shares
Last Trade
Dec 03, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.72M 399,987 shares
$9.30
$0.03

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up